166 related articles for article (PubMed ID: 38268989)
1. Whether Detection of Gene Mutations Could Identify Low- or High-Risk Papillary Thyroid Microcarcinoma? Data from 393 Cases Using the Next-Generation Sequencing.
Jin L; Zhou L; Wang JB; Tao L; Lu XX; Yan N; Chen QM; Cao LP; Xie L
Int J Endocrinol; 2024; 2024():2470721. PubMed ID: 38268989
[TBL] [Abstract][Full Text] [Related]
2. Co-existence of
Ren H; Shen Y; Hu D; He W; Zhou J; Cao Y; Mao Y; Dou Y; Xiong W; Xiao Q; Zhang Y; Su X
Cancer Manag Res; 2018; 10():1005-1013. PubMed ID: 29760568
[TBL] [Abstract][Full Text] [Related]
3. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Huang M; Yan C; Xiao J; Wang T; Ling R
Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059
[TBL] [Abstract][Full Text] [Related]
4. Precise Detection of Gene Mutations in Fine-Needle Aspiration Specimens of the Papillary Thyroid Microcarcinoma Using Next-Generation Sequencing.
Yu FX; Hu MX; Zhao HX; Niu LJ; Rong XY; Li WH; Zhu Q; Ying JM; Lyu N
Int J Endocrinol; 2019; 2019():4723958. PubMed ID: 30915113
[TBL] [Abstract][Full Text] [Related]
5. A Significance of Concomitant BRAF
Kuchareczko A; Kopczyński J; Kowalik A; Hińcza-Nowak K; Walczyk A; Pałyga I; Trybek T; Szymonek M; Gąsior-Perczak D; Gadawska-Juszczyk K; Mikina E; Płachta I; Suligowska A; Płusa A; Chrapek M; Łopatyński T; Góźdź S; Kowalska A
Thyroid; 2022 Nov; 32(11):1372-1381. PubMed ID: 35950639
[No Abstract] [Full Text] [Related]
6. Predicting factors of central lymph node metastasis and BRAF
Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm.
Silver JA; Bogatchenko M; Pusztaszeri M; Forest VI; Hier MP; Yang JW; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Nov; 50(1):63. PubMed ID: 34742355
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma.
Dong Y; Wang D; Luo Y; Chen L; Bai H; Shen Y; Zhang Y; Chen X; Su X; Zhao J; Liu H; Lu J; Yao Z; Zhao Y; He C; Li X
Oncol Lett; 2021 Mar; 21(3):188. PubMed ID: 33574927
[TBL] [Abstract][Full Text] [Related]
9. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
10. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
Wang Z; Gui Z; Wang Z; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Shi J; Wu P; Ji X; Zhang H; Sun W
Clin Endocrinol (Oxf); 2023 Apr; 98(4):609-621. PubMed ID: 36263602
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients.
Zheng X; Peng C; Gao M; Zhi J; Hou X; Zhao J; Wei X; Chi J; Li D; Qian B
Cancer Biol Med; 2019 Feb; 16(1):121-130. PubMed ID: 31119052
[TBL] [Abstract][Full Text] [Related]
12. [
Yang T; Chen C; Pan NF; Sun LY; Jiang XL; Li JN; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):919-924. PubMed ID: 31880125
[TBL] [Abstract][Full Text] [Related]
13. Association of BRAF
Attia AS; Hussein M; Issa PP; Elnahla A; Farhoud A; Magazine BM; Youssef MR; Aboueisha M; Shama M; Toraih E; Kandil E
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555268
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of high-recurrence risk papillary thyroid carcinoma in a southern Chinese population.
Li M; Jia H; Qian Q; Wen P; Chen C; Hua Y; Wang K; Zhang W; Shi F
Diagn Pathol; 2020 May; 15(1):49. PubMed ID: 32393293
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.
Samà MT; Grosso E; Mele C; Laurora S; Monzeglio O; Marzullo P; Boldorini R; Aluffi Valletti P; Aimaretti G; Scatolini M; Pagano L
Endocrine; 2021 Jan; 71(1):149-157. PubMed ID: 32621051
[TBL] [Abstract][Full Text] [Related]
16. Somatic genetic alterations in a large cohort of pediatric thyroid nodules.
Pekova B; Dvorakova S; Sykorova V; Vacinova G; Vaclavikova E; Moravcova J; Katra R; Vlcek P; Sykorova P; Kodetova D; Vcelak J; Bendlova B
Endocr Connect; 2019 Jun; 8(6):796-805. PubMed ID: 31085772
[TBL] [Abstract][Full Text] [Related]
17. Relationship between BRAF V600E gene mutation and the clinical and pathologic characteristics of papillary thyroid microcarcinoma.
Ji W; Xie H; Wei B; Shen H; Liu A; Gao Y; Wang L
Int J Clin Exp Pathol; 2019; 12(9):3492-3499. PubMed ID: 31934195
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of Ultrasound Imaging Characteristics and a BRAF V600E Nomogram for Central Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Zhu D; Wu X; Zhang L; Chen Z
Altern Ther Health Med; 2023 Nov; 29(8):139-143. PubMed ID: 37632946
[TBL] [Abstract][Full Text] [Related]
19. BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review.
Şahpaz A; Önal B; Yeşilyurt A; Han Ü; Delibaşı T
Balkan Med J; 2015 Apr; 32(2):156-66. PubMed ID: 26167339
[TBL] [Abstract][Full Text] [Related]
20. Younger Than 55 Years Old and
Lai Y; Gu Y; Yu M; Deng J
Int J Gen Med; 2023; 16():1403-1414. PubMed ID: 37155469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
